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The complexity of immune response-associated cells pres-
ent in normal human skin was recently redefll1ed as the 
skin immune sys tem (SIS) . In the present study, the exact 
immunophenotypes of lymphocyte subpopulations with 
their localizations in normal human skin were determined 
quantitatively . 
B cells were not found to be present in normal human 
skin. Lymphocytes were always of T-cell type, and 90% 
of these T cells were clustered in 1-3 rows around postcap-
illary venules of the papillary vascular plexus or adjacent 
to cutaneous appendages. In such perivascular localizations, 
they were found to differ from their circulating counter-
parts in three ways . 
First, skin perivascular cells were found to be approxi-
mately evenly distributed over CD4 + inducer and CD8 + 
suppressor-cytotoxic T-cell subsets (mean CD4/CD8 ratio: 
papillary layer 0.96, reticular layer 0.99). Second, w ithin 
the category of CD4 + inducer T cells, most were phe-
T he skin has been suggested to be a first-l evel lymphoid organ, in w hi ch "the lymphocytes reachin g the epi-dermis may to a large ex tent be non competent lym-phoid cells that become competent durin g or shortly after a stay in the epidermis or close to it in the cor-
iun." [1]. Support for such an assumption ca me largely from 
studies (reviewed in [2]) that showed the presence in and lo r pro-
duction of "immunomodulating" mediators by keratin ocy tes. 
Presence of intraepidermallymphocy tes was probably first de-
scribed by Kondo in 1922 [3]. Therea fter, a 1949 stud y by An-
drews and Andrews [4] indicated that 1-4% of the cell s in the 
germinative (basal) layer were lymphocytes. More recently, Smolle, 
E h all , and Kerl [5], usin g mOI~ocl onal antibody (MoAb) OKT1 '1 
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Abbreviations: 
AMLR: auto logous mixed leukocyte rcact ion 
AP: alkaline phosphatase 
BALT: bronchus-associated lymphoid ti ssue 
notyped as CD4 +, 4B4 + helper inducer T lymphocytes, 
whereas CD4 +, 2H4 + suppressor indu cer T lymphocytes 
were found to be relatively rare (l ess than 5%). Third , the 
majority of skin perivascul ar T cells w ere activated as they 
expressed HLA-DR and interleukin 2 receptors. 
In traepidermal, directly subepidermal, and other ("free") 
lymphocytes were mostly of the C D8 + suppressor-cy to-
toxic T-cell subset but accounted for less than 10% of the 
total number oflymphocytes. Intraepidermally loca lized T 
cells accounted for less than 2% of the total number of 
lymphocytes present in normal skin. Our results indicate 
that preferential perivascular localization of activated T 
lymphocytes is the characteristic of normal human skin . 
This might be a refl ection of continuous antigen recogni-
tion upon endothelia l cell presentation and /o r continuous 
T cell-mediated endothelia l cell activation thereby indu cing 
enhanced antigen clea ring by the skin's endothelium. ) 11/-
llest Dermato! 88:569-573, 1987 
(CD2 [6]) observed 46 ± 11 T cell s per mm2 vertica l epiderm al 
section. Cooper et al (7] cou ld no t identify any intraepiderm al T 
cell s in either horizontal o r verti cal skin sections usin g pan T-cel l 
markers Leu-l and OKT3 (CD3). They also reported the results 
of flow cy tometri c ana lys is of epidermal cell suspensions of 3 
experim ents, in which T cells (Lell-l +) represented 0. 16% of 
epiderm al cells. Atkinson et 31 [8] no ted absen ce of epiderm al T-
cells in 13 of 20 skin biopsies of normal persons. It thus appears 
th at the res ults regarding the quantifi cation ofintraepidermall ym-
phocytes have been inconsistent. 
In the present stud y, we describe the distributi on ofl ymphocyte 
sllbpopulations as defined by MoA b both in the epidermis and 
dermis of normal hum an skin (24 biopsies obtained fro m different 
sites of different donors) . 
C D: cluster of differentiation 
Con A: concanava lin A 
DAL T: duct-associated lympho id tissue 
GALT: gut-associated lymphoid ti ssue 
IL: interleukin 
MoAb: monoclonal antibody(-ies) 
PO: peroxidase 
PWM: pokewecd mitogcn 
SIS: skin immune sys tem 
UEA-I : Ulex CII I'OP CII S agglu tinin 1 
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MATE RIALS AND METHODS 
Biopsies A tot:l l of24 biopsies were included in this stud y. All 
were obt:lined und er 10c:l I Xy loc:line infiltr:ltioh ancsthes i:l from 
c1inic:llly and histo log ic3 11 y normal, contraiatct3 1 ski n of p:lticnts 
with essenti:lll y loca lized sk in lesio ns such as nev i. Biopsies thus 
takcn we re obtai ned from thc uppcr limb (5), sho ulder regio n 
(6), ba ck (6), chcst (2), abd o m en (2), o r lower limb (3). T iss ue 
spccimens wcre frozen in liquid n itrogCll 3n' \ sto red :I t - 90°C 
until usc. 
Monoclonal Antibodies M o noclo nal :lIltibod ies, th cir speci-
ficity , cl uster of differentiation (CD) defi nitio n (if :lV:l ilable) , 
workin g di lu tion , and so urce arc stated in Table I. M o noclonal 
antibod ies RIV 9 (CD3), R IV6 (CD4), and RIV4 (CD8) were 
obta in ed as pure ascites from the Rijksinstituut voo r Vo lksge-
zondheid en Milieuh ygiene, Bi lthoven, The N eth erlands. The 
spccifi city of these M oAb was previously eva luated (P. K. Das, 
in preparation) for usc in bo th no rm al and diseased sk in biopsies 
by comparin g them w ith the Leu series. Althoug h CD4 is also 
known to be present o n Langerhans cell s in very sma ll amounts 
19, 10 ], the direct immunohistoche mi ca l techniqu e used here (al-
kaline phosphatase = AP-I abeled H. IV6) fa iled to stain them, 
almost certa inl y due to the kn own low sensib ility threshold of 
such a m ethod. 
Alkaline Phosphatase Labeling of Monoclonal Antibodies 
Alkaline phosph:ltase I3beling of M oA b W:lS performed acco rding 
to the worki ng in st ru ct ions of AP supplier Boehringer M an nheim 
(M annh eim, F.I<'.G.). In sho rt, AP W:lS activ3ted by g lut:lri c di-
:l ld eh yde (Flu ka, Buchs , Switzerl and) treatmen t. Activated AP 
(3 .5 mg) W3S then mi xed with protein A Sep harose (plurm3cia , 
Uppsal3 , Swedcn)-p urifi ed IgG fr:lction of M o Ab (1. 5 m g) . N ext, 
the MoAb-Ai> conju gJte W:lS purifi ed by AcA44 Ultroge l (LKB, 
Societe C himique Po in tet G irard , Villeneuve-Ia-Garenne, France) 
chro m atography Jnd sto red in the presence of I 'X, bovine serum 
albumin and thi o m ersa l 0.01 % at 4°C. 
Double Staining Procedure Seve r31 different double-stainin g 
techniques were eva lu ated to id entify 2 ce llular co nstituents in the 
ski n sections simultaneously. T he fo llowin g m ethod was found 
to be the most sat isfacto ry d ue to the clarity and reproducibility 
of the results obta in ed. Double stJi nin g was ca rried o ut by sub-
seq uent in cubation of cryosta t-sectioned 6 /Lm-thi ck vertica l skin 
sect io ns placed o n polylysine-pretreated slid es w ith the fol lowin g 
in the orde r stated: (1) unl3beled M oAb "a" (60 m in), (2) per-
ox idJse (pO)-labeled rabbit-anti m o use IgG (Dakopath, G lostrup , 
Denmark) (work in g di lu tion '1 :50; 30 min), (3) no rl11 al m o use 
se rul11 (N ord ic, T ilburg, The N etherl and s) (10 min ), and (4) AP-
labeled M oAb " b" (60 min ). 
Sectio ns were rin sed 3 times in ph osphate-buffered sa line (pH 
7.2) in between successive in cuba t io ns. The AP 3ctivity was de-
tected histoche mi ca ll y acco rdin g to Burstone 1111 ; a blue co lo r 
was developed usin g naphtol-AS-MX-phosphate (S ig ma , St. Lo uis, 
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Missouri) as substrate and Fast Blue 1313 (Sigma) as azo dye. 
Endogeno us AI> activity W3S inhibited w ith levamizolc 1 m M 
(Sigma) included in the in cubat io n m ed ium. The last s tep then 
consistcd of detecting PO activ ity usin g 3-3m in o-9- ethy l-ca rbazol 
(A EC) g ivi ng :In o ran ge-red reacti o n prod uct. In this methoq , 
double-stained cells could be identified by th eir purp le stain . 
The st3 inin g re:lct io n was visuall y controlled and stopped by 
was hin g in acetate buffer. Slides were fi xed in forl11aline (4%) . 
Fina ll y, sect io ns were m o unted w ith g lycerin-gelatin without 
countersta inin g. Process in g of ti ssue specimens, id entifi ca ti o n of 
ccll types, immuno peroxidasc technique, and the control s used 
were essentiall y thc sa m e as described before 11 2, 13 1. 
Labeling Combinations 1. Perox idasc-l3beled Ulex c"ropells 
agg lutinin 1 (UEA-l: wo rkin g dilution I :WO; obt:l in ed from E-
Y Laboratories, S:ln M :lteo, C:l lifo rnia ) x RIV 9 (CD3) indirectl y 
I3belcd w ith A P-conjugated rabbit anti m o use Ig (workin g di lu-
tion 1 :5, Dakopath, G lostrup, Denmark). This co mbin ation al-
lowed identificat ion and loca liza ti o n ofT cells in relati o n to ly mph 
and blood vessels as th eir endotheli al cel ls have been shown to 
exp ress U EA- I , a lect in that is useful fo r cndothe lial-cell iden-
tifi cat io n /1 4 1. 
2. Unlabel ed anti-HLA-DR x AP-Iabeled RIV 9 (CD3), a ll ow-
in g identifi ca tio n of MH C II expressin g, activated T cells. 
3 . Unlabe led anti-Tac (CD25) x AP-Iabeled R IV9 (CD3), al-
lowi ng identifi cation of inter leu kin 2 (IL-2) rece ptor-positive, ac-
ti vated T cell s [151. 
4 . Unl abeled RIV4 (CDS) x AP-iabeled RIV 6 (CD4), all owing 
determination of in situ induccr/suppresso r-cytotoxic T - cell ra-
tios . 
5. Unl3beled 2H4 x All-labeled RIV 6 (CD4), allowin g iden-
tific:ltion of the CD4"', 2H4 '" suppresso r indu cer subset of inducer 
T cell s /1 6 1. 
6. Unl abeled 4B4 x AP-I abelcd RIV 6 (CD4) , all owin g iden-
tification of the CD4"', 4B4 '" helper indu cer subset of indu ce r T 
ccll s /171. 
A Iso, anti-B 1 (CD 19) W:lS used as a B -cell marker in a two-
st:lge immunoperox id:lse assay using PO -labeled rabbit anti-
m o use IgG as the second step. 
Lymphocyte Enumeration Stained cell s were counted in 2 
sequenti al scct io ns of each spccimen in which the skin was st rat-
ified into ho rizontal layers: within the ep idermis in to supra basa l 
and interb:lsa l layers; within the papi llary layer of the dermis into 
directly subepidermal, peri vascular, and o ther ("free") layers; and 
within thc rcticul ar dermis into perivascu lar , adnexa l perivascul ar , 
and other ("free") laycrs . T he 2 va lu es for each stai nin g :lnd each 
stratifi cat ion were adjusted to 10-mm hori zontal section va lues 
by di v iding with the ho rizonta l width multiplied by 10. The m ea n 
va lue of cach biopsy was then used for the determ in:ltio n of total 
m ea n, medi an , :lnd ranges of lymphocyte numbers. H o rizontal 
w idth of sections r:l nged from 1.52-3.38 mm, with a m e:ln of 
2.58 111m and a m ed ian of2.67 mm. 
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RE SULTS 
B Lymphocytes U sin g M o Ab anti-B l (CD19), no t a sin g le 
stai n e d cell could be o bserved in an y of th e 24 bio psies (duplica te 
sectio ns of each bio psy). Similar nega ti ve findin gs were prev i-
o u s l y fo und in contro l ex perim ents using B-cell m arkers mo no-
clo n a l anti-kappa and -lambda 19 li ght chain s [12,13\. 
T Lymphocytes Usin g pan T - cell marker HlV9 (C D3), w hi ch 
was indirectl y labeled w ith AP to allow do uble staining w ith PO-
conju ga ted Ulex e/lropc/l s lectin , th e exact number and loca lizat io n 
(a lso in rel atio n to skin vascul ature) o f T cells could be eva lu ated . 
To ta l number o f bio psies stu d ied (duplica te sections o f each bi-
opsy), tota l mea n number, m edian, and ranges, all adju sted to 
10-ITlI11 ho rizo ntal secti on, are summ arized fo r each skin layer in 
Ta bl e II . 
It i s e vident that the llIaj o rity o f the T cells o f no rm al skin are 
locali zed aro und the postca pill ary venul cs of the superfi cial and 
deep vascul ar netwo rks of skin. In there, th ey we re m ostl y lo -
ca li zed in 1-3 rows around th e vessel (Fi g '1) . T hese peri vascul ar 
T cell s co mprise mo re than 90% of the tota l mean number o f T 
cells in skin (T able II: 258.92 + 93.44 + 64.17 o f to tal m ea n 
447.5) . lntraepide rm al T cell s acco unt fo r onl y 2% o f th e to tal 
mea n number o f no rlllal skin T cells (T abl e II : 4.4 1 + 4.20 of 
total m ean 447.5). 
Perivascular T ce lls ranged substan tiall y due to the va ria bility 
in vascular length present in th e indi vidual skin sectio n. In cidental 
presen ce o f large vessels thus gave in cidental hi gh numbers of 
perivascular T ce lls . 
Table II. T-C ell M arkers in Vari ous Skin Laye rs 
CD3 +. CD3 +, 
C D3+ HLA- DR - IL-2-
Epidermis 
Su p rabas,,1 N 24 24 21 
Mn 4.4 1 2.02 2.74 
Me 3. 1\ o.on 000 
1  0.OO- IS.3S 0.00- 1'). 17 0.00-43.55 
In te rbasa l N 24 24 21 
Mn 4.21l 0.44 0.62 
Me 3.54 000 0.00 
I ~ 0.00-17.24 0.00-3.77 0.00- \. 88 
Papi ll a ry Layer 
Su bepidenn al N 24 24 21 
Mil 4.60 0.91 0.42 
Me 3.39 0.00 0.00 
I{ O.OO-20.W 0.00-5.62 0.00-3.75 
Free N 24 24 21 
Mn 11 .30 2.67 2.54 
Me 1\. 82 0.80 0.00 
R 2.45-24. 14 0.00- 13.74 0.00-20.\18 
Peri vascular N 24 24 21 
Mn 258.\12 25 .52 47 .95 
Me 234.26 20.59 44 .\18 
11 \18.9 1-520. 16 \. 93-6 \. 5\1 O.OO-S4.S2 
Ret icular Layer 
Free N 24 24 1\1 
Mn 6.44 0.44 0.23 
Me 5.22 0.00 0.00 
1  0.00-30.36 O.OO:....S.50 0.00-2.63 
Pe ri vascular N 24 24 19 
Mil \13.44 14.S\I 2 I.()6 
Me %72 6.S I 1\1.3 1 
1< 14. n-185. 72 0.00-84.27 0.00-68.84 
Peri vascular adn ex N 14 15 12 
Mil 64. 17 6. 17 \1.78 
Me 20.72 1.75 4.43 
R 0.00-275.S6 0.00-45.29 0.00-49.06 
Tota l mean count 447.5 53.0 85.0 
Mea n s (Mn), medi ans (Me), aud ranges (R) adjusted to IO-1ll1ll horizonta l section 
of pan-T cclluumbcrs (CDY) and num bers o f nonacti vated T cells (CD3 +, H LA-
DR - , a nd CD3 ; . I- L2 - ) at different loca lizations of norlll al hUlll an skin . Num ber 
of skin biopsies co unted (N) is g iven. 
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Figure 1. Schematic representa tion (not to scalc) of tissue distribu tion 
and iml11unophenotypc of IYl11ph ocytes of the SIS. In this drawing, the 
actual number of each lymphocyte subset is approx il11atel y equal to the 
Ill ea n va lue obta ined in this se ries of 24 norl11 al hum an skin biopsies, 
adjusted to 10-111111 section width . E, epiderl11i s; PL, papillary b yeI': RL, 
reti cu lar b ycr; SC , swea t gland; 1-/1", hair fo lli cle. 
Activated T LYlnphocytes In o rd er to know w hether o r not 
the T cell s of the skin immune system (SIS) were in an acti va ted 
state, double-sta ining procedures were applied in w hich anti-H LA-
DR and anti-T ac (CD25 : IL-2 recepto r) were taken as m arkers 
fo r activa tion . Al ka linc phosphatase-labeled R1V9 (CD3) was used 
w ith either anti-HLA- D R o r anti-Tac (CD2S) indi rectl y labeled 
w ith PO. During initial o bserva tio ns in this study, it beca m e 
evident that a m aj o rity of skin T cells expressed these activation 
m arkers. T herefo re, to m ake countin g m ore convenient , the 
numbers o f C D3 +, H LA-D R - and C D3 +, anti-Tac (CD25)-
ncgative cell s in each skin layer were determ ined. To tal number 
o f bio psies evaluated , mea ns, m edians, and ranges arc all sum-
m arized in T able II. 
M ea n C D3+, HLA-D R - counts were alm ost always slightly 
lower co mpared with C D3 +, anti-T ac (CD25)-negative T - cell 
numbers . T his might be ex pl ained by som e in te rference o f o ther 
HLA-DR + cells (i.e . , Langerhans cell s, tissue m acro phages, 
endotheli al cells) located in close proximity to HLA- D R - T cells, 
g ivin g a fa lse impressio n o f HLA-D R positi vity. 
Takin g anti-Tac (CD25) nega ti v ity as a s li ghtl y m o re rel iable 
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Table III. T -Cell Markers in Various Sk in Layers 
CD4/CD8 ratio CD4 +. 4B4 - CD4 +.2H4 + 
Epidermis 
Suprabasa l N 23 24 21 
Mn 0.32 0.46 0.22 
Me 0.00 0.00 0.00 
R 0.00-2.50 00.00-4.46 0.00-2.75 
Interbasa l N 23 24 21 
Mil 0.17 0.00 0.09 
Me 0.00 0.00 0.00 
R 0.00- 2.00 0.00-0.00 0.00-1.93 
Papi llary Layer 
Subepidermal N 23 24 21 
Mn 0.1 0 0.45 0.08 
Me 0.00 0.00 0.00 
R 0.00-0.50 0.00-3.92 0.00-1.73 
Free N 23 24 21 
Mn 0.17 0.82 0.00 
Me 0.00 0.80 0.00 
R 0.00-1. 00 0.00-5.27 0.00-0.00 
Perivascular N 23 23 21 
Mn 0.96 10.34 11. 08 
Me 0.91 10.35 10.34 
R 0.25-2.66 0.00-26.2 1 0.00-27.68 
Reticular Layer 
Free N 20 23 16 
Mn 0.00 0.00 0.38 
Me 0.00 0.00 0.00 
R 0.00-0.00 0.00-0.00 0.00-6.05 
Perivascular N 20 23 16 
Mn 0.99 5.36 4.75 
Me 0.97 2.63 4.47 
R 0.00-1.78 0.00-23.55 0.00-10.45 
Perivascular adnex N 11 16 11 
Mn 1.19 0.91 3.71 
Me 1. 00 0.00 1.88 
R 0.26-3.29 0.00-6.90 0.00-17.38 
Tota l mean COLlllt 18.4 20.3 
Means (M n). medians (Me). and ranges (R) adj usted to IO-mm horizontal section 
of CD4/C D8 ratios and numbers of true helper suppressor T cells (CD4 + . 4B4 - . 
and CD4 +. 2H4 +) at different localizations of normal human ski n. Number of ski n 
biopsies counted (N) is given . 
marker and anti-HLA-DR negativity as a control value. it was 
thus found that, with the exception of the suprabasally localized 
T cells, activation markers were present in more than 75% of the 
SIS T lymphocytes (Table II : 85.0 of 447.5 total mean not ex-
pressing IL-2 (CD25)). 
CD4/CD8, Inducer/Suppressor-Cytotoxic T CeIl Ratios 
Total number of biopsies evaluated, means, medians, and ranges 
of CD4/CD8 ratios in each layer are summarized in Table III. 
Within the perivascular T cell areas of SIS, CD4/CDS ratios were 
always approximately 1. This contrasted w ith the finding of gen-
erally low ratios in all other areas of normal skin, where CD4/CDS 
ratios were very much in favor of the suppressor-cytotoxic T -
cell subset (Table III : ratios of 0.32. 0.17, 0.10, 0.17, and 0.00, 
respectively). "Free" T cells within the reticular dermis were 
always of the CDS + subset; CD4 + inducer T cells were virtually 
absent. T hese results have also been incorporated in Fig 1. which 
gives a proportional picture of the T-celJ subsets in normal human 
skin. 
4B4 + Helper Inducer and 2H4 + Suppressor Inducer Sub-
subsets of the CD4+ Inducer T-Cell Subset Alkaline phos-
phatase-labeled anti-CD4 (RIV6) was used with ei ther 2H4 or 
4B4 that were indirectly labeled with PO . In this way the number 
of2H4 + suppressor inducer as well as the number of 4B4 + helper 
inducer T cells could be determined. Preliminary observations 
with this set of T-cell markers indicated that the majority of 
inducer T cells of the SIS were of the 4B4 + helper inducer sub-
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subset. Therefore, to make countin g more conven ient, CD4 +, 
4B4 - , and CD4 + 2H4 + cell s were coun ted. 
Total number of biopsies evaluated, means, medians. and ranges 
are all summarized in Table III. Results clearly indicate that only 
a small percentage of the CD4 + inducer T cell s were of the sup-
pressor inducer sub-subset . Perivascular suppressor inducer T 
cells accounted for less than 5% of the total number ofCD3 + T 
cells observed (Table Ill : 11.0S + 4.75 + 3.71 of total mean 447.5 
of Table 1I) . T hese find ings are hi gh ly different from findings in 
peripheral blood [1 6,17]. C ircul ating CD4 + cells are 41 ± 2% 
4B4 reactive and 41 ± 5% 2H4 reactive. 
DISCUSSION 
In this stud y, evidence is presented that lymphocytes of the SIS 
[2] are exclusively T cells; B lymphocytes were never observed. 
It seems justified to conclude that B cells do not occur in normal 
human skin. They thus may not form a constituent of the SIS. 
Intraepidermal T cells are relatively rare and accoun ted for less 
than 2% of the tota l number of T cells coun ted in this series of 
normal human skin biopsies. Accumulations of T cells directly 
subepidermal were never observed . Thus, these resul ts do not 
seem to support the hypothesis that T cells are continuously ma-
turating/differentiating in a close spatial relationship w ith kerat-
inocytes. Our results as well as those of Smoll e, Ehall , and Ked 
[5], Cooper et al [7], and Atkinson et al [S], however, do not 
exclude such an interaction at an earlier developmental age or at 
special localized as yet undefined skin sites. 
Although keratinocytes may produce "immunomodul atory" 
mediators (reviewed in [2]). their actual production (in vitro) has 
been demonstrated only for IL-1 , which is not a very specific 
finding, as IL-l may be produced by a wide variety of other cell 
types includ ing monocytes, Langerh ans cells, fibroblasts, and 
endothelial cells (reviewed in [l S]) . 
T he presence of rare scattered intraepidermally localized T cells 
of mainly the suppressor-cytotoxic subset (mean CD4/CDS ratio 
= suprabasa l 0.32; interbasal 0.17) is difficult to explai n. The 
question remains whether these are the cytotoxic T cells capable 
of recognizing altered self while migrating in a gradient of au-
toantigens produced by aberrant and potentially ma lignant ke-
ratinocytes as hypothesized by Strei lein [1 9]. 
T he results of our study of the dermis indicate that T cells 
normally occur in 1-3 rows around some but not all venules of 
the superficial vascular plexus, presumably around the postcap-
illary venules, and around the venules of the skin appendages (Fig 
I) . Their distribution over the 2 major T -cell subsets varies but 
is generally almost eq ual (mean CD4/CDS ratio = 0.96) . In ad-
dition, the majority of them are activated as they express HLA-
DR and receptors for IL-2 (anti-Tac +). 
T he human CD4 + inducer T -cell subset may be further sub-
divided into 2 major subpopulations that are phenotypically and 
functionally distinct. Recently, Morimoto et al [1 6.17] were able 
to develop 2 convenient M oAb (4B4, 2H4) that can be used for 
this purpose. The CD4 +. 4B4 4o , 2H4 - subpopulation proliferates 
poorly upon stimulation with concanavalin A (Con A) and au-
tologous cell antigens in a autologous mixed leukocyte reaction 
(AMLR). T hey proliferate well on exposure to soluble antigens 
and they provide a good helper signal for pokeweed mitogen 
(PWM)-induced Ig synthesis. The CD4 +, 4B4 - , 2H4 + subset 
proliferates ':Veil to Con A stimulation. but poorly to soluble 
antigen stimulation, and provides poor help to B cells for PWM-
induced Ig synthesis. M ore important. this CD4 +, 4B4 - . 2H4 + 
subpopulation functions as the inducer of the CDS + suppressor 
cells. CD4 + inducer T cells can thus be divided into 2H4 + sup-
pressor inducer and 4B4 + helper inducer su bpop ulations . 
In this work, the relative rarity of double-stained CD4 +, 2H4 + 
T cells and the presence of many double-stained CD4 + . 4B4 + T 
cells in the perivascu lar T-cell infiltrates indicates they are almost 
exclusively of the helper inducer subpopul ation. Their spatial 
relationship with HLA-DR + endoth elial cells, their expression of 
activation markers HLA-DR an d IL-2 receptors, and their inclu-
VOL. 88. N O 5 MAY 1987 
sion in t he helpe r inducer subpopubtion of the ind ucer T - ce ll 
subset, all su gges t that they pro life rate upo n stimul ation by un-
defi n e d soluble antigens , presented to t hem by endothelia l cell s 
w hic h h ave been demons trated to be capable of anti gen presen-
tation 120, 21 ]. One mi g ht specul ate th at they a re invol ved in the 
continuous process in g o f exogeno us and endogeno us (neo)antigens. 
T h ey even may indu ce HLA-DR expression by end othelia l ce lls 
[22] a n d he lp them in anti gen clear in g. T hey do not seem to be 
part of an in v ivo equi va lent of the AMLR , as they have been 
de mons trated to res po nd poorl y in suc h an in vitro s ituation 11 7 1. 
If a ny " hom ing" T ce lls ex ist w ithin the skin, th e pe rivascula r T 
cell s are the mos t likel y candidates, alth o u g h their expression of 
activation m arkers docs n ot seem to support such an ass umptio n , 
as homin g T cells mi g ht be ex pected to be at res t , rather than in 
an activated s ta te. 
It i s inte res tin g to co mpare the ly mph ocytes of n o rm al hum an 
skin as d escribed he re with what is kn own about the ly mph ocytes 
of g ut-associa ted ly mpho id tissue (GALT) [231. bronchu s- asso-
ciated ly mph oid tissue (BALT) [241, or even du ct-associated lym-
phoid tissue (DAL T) 125 1. In the tissues GALT, BALT, and DALT 
that m ay be sUlllm ari zed as the com m o n mu cosa l immune sys-
tem, .one primaril y find s B cells w ith their auto no mous (i .e . , 
unrelated and uninflu en ced by the remainder of t he body 's im-
mune systems) capa city to differentiate into secreto ry Ig A-pro-
ducin g pl as m a cells. Our findin gs, both as to the absen ce of B 
cell s a nd the lack of evide n ce for keratinocyte-T ce ll interactio ns 
in normal human skin h ave made us questi o n the co ncept of skin-
associated lymphoid ti ssue (SA LT) [1 9,261. We have tried to re-
defme t h e immune res po nse-related cells of no rm al hum an skin 
as the S IS [2] in order to avoid confus ion w ith the qualitativel y 
diffe r ent mu cosa l-associated ly mph o id tiss ll es GA L T, BAL T , and 
DAL T, amon g other reason s. In o th e r words , SIS ma y n o t be a 
compartmentali zed part of th e hum an immun e sys te m , in cont rast 
w ith the co n stituents of the co mm o n mu cosa l immune system. 
F u nhe r fun ction al s tudies on the ph ys io logic role of the di f-
fe rent lymphocyte subsets present in no rmal human skin are needed. 
At this mome n t, imll1unoph enotyping cannot an swer w hether 
these cells a rc just wanderin g, recruited, o r res ident. 
lnge Oosterlillg is gra teji.dly ack'lOwlcl(ged for ir eI' expert d/'awillg of Figllre '1, 
N. C. /-IlIrtw(g II lld R. F. /-I. J. /-1,,1511' 11 115 for t/r eir /relp ill Ob(lI illillg skill 
biopsies , J. Oostillg fo r skilljid IIssistll ll ce ill Illllll cri[(/ l IIIwlysis, alld T. A. 
Wa ldmanll for pro"id;Il.~ 115 wit/r II/,ti- Ta c. 
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